Tailoring Treatment Approaches for Rapid vs. Slow Disease Progression in CLL

Panelists discuss how treatment approaches are tailored differently for patients with rapid, aggressive chronic lymphocytic leukemia progression versus those with slower, less aggressive disease, considering factors such as urgency of intervention, choice of therapy intensity, and long-term management strategies.

EP: 1.The Current Treatment Landscape for R/R CLL

EP: 2.Impact of Prior BTKi vs BCL2i Therapy on Treatment Decision-Making in CLL

EP: 3.Key Patient-Specific Factors Guiding Treatment Selection in CLL

Now Viewing

EP: 4.Tailoring Treatment Approaches for Rapid vs. Slow Disease Progression in CLL

Video content above is prompted by the following:

• How does your treatment approach differ for patients with rapid, aggressive disease progression compared to those with slower, less aggressive progression?

Related Videos